Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 18
Clinical Trials
Clinical Trials | 24 January 2022

RaphaCure partners with Madhavbaug for cardiac healthcare services

Madhavbaug has a pan-India presence with a vast network of 272 clinics and two hospitals

Clinical Trials
Clinical Trials | 30 December 2021

Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA

The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness

Clinical Trials
Clinical Trials | 28 December 2021

RaphaCure partners with Zeebon for foraying into North East market

Zeebon is the largest diagnostics services provider in North-Eastern states

Clinical Trials
Clinical Trials | 10 December 2021

Lupin enters the diagnostics business

Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.

Clinical Trials
Clinical Trials | 08 December 2021

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months

Clinical Trials
Clinical Trials | 07 December 2021

Fujifilm collaborates with DCC Animal hospital for diagnostics support

Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.

Clinical Trials
Clinical Trials | 03 December 2021

Neuberg Diagnostics expands to North India

Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time

Clinical Trials
Clinical Trials | 29 November 2021

AMPATH launches its pathology laboratory in Mumbai

The company has has 10 existing labs in India

Clinical Trials
Clinical Trials | 11 November 2021

LifeCell Diagnostics expands newborn screening portfolio

LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns

Clinical Trials
Clinical Trials | 27 October 2021

Dr Lal PathLabs to acquire Suburban Diagnostics for Rs 925 crore

Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21

Clinical Trials
Clinical Trials | 16 October 2021

Metropolis Healthcare board approves acquisition of Hitech for Rs 636 crore

The revised deal involves a cash consideration only as against the earlier proposal of cash and equity

Clinical Trials
Clinical Trials | 29 September 2021

Morpen Labs carves out diagnostics business to unlock value

The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India

Clinical Trials
Clinical Trials | 24 September 2021

Surgery added to Practo’s offerings

The company will leverage existing hospital and clinic partners’ infrastructure to build specialised `Experience Centres’ and facilitate a seamless, end-to-end secondary care surgery delivery. It will also offer healthcare financing

Clinical Trials
Clinical Trials | 20 September 2021

RxDx Healthcare receives NABL accreditation

RxDx is a chain of primary care driven multispecialty healthcare clinics with two main branches situated in Whitefield and Malleswaram in Bengaluru

Clinical Trials
Clinical Trials | 20 September 2021

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal

The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021

Clinical Trials
Clinical Trials | 20 September 2021

Mylab Discovery Solutions acquires Sanskritech in an all-cash deal

The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021

Clinical Trials
Clinical Trials | 14 September 2021

Prevest DenPro Limited's IPO to open on BSE SME platform on September 15

The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities

Startup

Digitization